Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18962)

• Formulation Name: Rifabutin 150 mg capsule
• Company: Avera McKennan Hospital; Lupin Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Rifabutin	(DM1YBHK)	Mycobacterium infection	1B10-1B21	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Crospovidone	(E00626)	Not Available	Disintegrant
Eisenoxyd	(E00585)	56841934	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent